The Issue

Medical cannabis has well-documented analgesic properties that make it an effective medicine to treat many cases of chronic pain. It is an especially important option for patients for have found traditional pain relief options ineffective, and it may have fewer side effects and risks than some traditional medications.

The Problem

As of February 2024, medical cannabis is permitted in 47 states, the District of Columbia, and three U.S. territories (Guam, Puerto Rico, and the U.S. Virgin Islands). Thirty-eight of these states, along with the District of Columbia and three territories, have comprehensive programs allowing for cannabis products beyond CBD or low-THC. Fourteen states and two territories have medical-only programs, while nine states restrict access to CBD/low-THC products for qualifying conditions. However, despite the prevalence of these programs, access is often limited to specific patient populations, meaning many individuals with chronic pain are excluded from potentially beneficial treatments. This patchwork of policies creates disparities in access to medical cannabis for people living with chronic pain across different states and territories.

Our Position: Legalize medical cannabis

We believe people with chronic illness and pain should have access to all safe, effective treatments, including medical cannabis. Read our full position statement here.

Get Involved

• Sign up to be a U.S. Pain advocate and get action alerts straight to your inbox